Literature DB >> 26937136

Glycosyltransferases and non-alcoholic fatty liver disease.

Yu-Tao Zhan1, Hai-Ying Su1, Wei An1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease and its incidence is increasing worldwide. However, the underlying mechanisms leading to the development of NAFLD are still not fully understood. Glycosyltransferases (GTs) are a diverse class of enzymes involved in catalyzing the transfer of one or multiple sugar residues to a wide range of acceptor molecules. GTs mediate a wide range of functions from structure and storage to signaling, and play a key role in many fundamental biological processes. Therefore, it is anticipated that GTs have a role in the pathogenesis of NAFLD. In this article, we present an overview of the basic information on NAFLD, particularly GTs and glycosylation modification of certain molecules and their association with NAFLD pathogenesis. In addition, the effects and mechanisms of some GTs in the development of NAFLD are summarized.

Entities:  

Keywords:  Glycosylation; Glycosyltransferases; Non-alcoholic fatty liver disease; Pathogenesis

Mesh:

Substances:

Year:  2016        PMID: 26937136      PMCID: PMC4768194          DOI: 10.3748/wjg.v22.i8.2483

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  114 in total

Review 1.  Glycosyltransferase structure and mechanism.

Authors:  U M Unligil; J M Rini
Journal:  Curr Opin Struct Biol       Date:  2000-10       Impact factor: 6.809

Review 2.  Structural and functional features of glycosyltransferases.

Authors:  C Breton; J Mucha; C Jeanneau
Journal:  Biochimie       Date:  2001-08       Impact factor: 4.079

3.  Endoplasmic reticulum export of glycosyltransferases depends on interaction of a cytoplasmic dibasic motif with Sar1.

Authors:  Claudio G Giraudo; Hugo J F Maccioni
Journal:  Mol Biol Cell       Date:  2003-05-18       Impact factor: 4.138

4.  The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase.

Authors:  Rajindra P Aryal; Tongzhong Ju; Richard D Cummings
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

Review 5.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

6.  Genomic structure and promoter analysis of the human alpha1, 6-fucosyltransferase gene (FUT8).

Authors:  Y Yamaguchi; Y Ikeda; T Takahashi; H Ihara; T Tanaka; C Sasho; N Uozumi; S Yanagidani; S Inoue; J Fujii; N Taniguchi
Journal:  Glycobiology       Date:  2000-06       Impact factor: 4.313

Review 7.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

8.  Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase.

Authors:  René Jørgensen; Thomas Pesnot; Ho Jun Lee; Monica M Palcic; Gerd K Wagner
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 9.  Role of gut barrier function in the pathogenesis of nonalcoholic Fatty liver disease.

Authors:  Xin Dai; Bangmao Wang
Journal:  Gastroenterol Res Pract       Date:  2015-04-05       Impact factor: 2.260

Review 10.  Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.

Authors:  Seung-Hoi Koo
Journal:  Clin Mol Hepatol       Date:  2013-09-30
View more
  5 in total

1.  Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.

Authors:  John D Clarke; Petr Novak; April D Lake; Rhiannon N Hardwick; Nathan J Cherrington
Journal:  Liver Int       Date:  2017-02-07       Impact factor: 5.828

2.  Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats.

Authors:  Xu-Jia Chen; Wen-Jing Liu; Meng-Liang Wen; Hong Liang; Shao-Mei Wu; Yun-Zhen Zhu; Jiang-Yuan Zhao; Xiang-Qian Dong; Ming-Gang Li; Li Bian; Cheng-Gang Zou; Lan-Qing Ma
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

3.  Hepatoprotective Effects of Insect Extracts in an Animal Model of Nonalcoholic Fatty Liver Disease.

Authors:  A-Rang Im; Won-Kyung Yang; Yang-Chun Park; Seung Hyung Kim; Sungwook Chae
Journal:  Nutrients       Date:  2018-06-07       Impact factor: 5.717

4.  Integrative analysis of transcriptomic data related to the liver of laying hens: from physiological basics to newly identified functions.

Authors:  Audrey Gloux; Michel J Duclos; Aurélien Brionne; Marie Bourin; Yves Nys; Sophie Réhault-Godbert
Journal:  BMC Genomics       Date:  2019-11-07       Impact factor: 3.969

5.  Overexpression of glycosyltransferase 8 domain containing 2 confers ovarian cancer to CDDP resistance by activating FGFR/PI3K signalling axis.

Authors:  Shuting Huang; Suiying Liang; Guandi Chen; Jing Chen; Keli You; Haiyan Ye; Zhigang Li; Shanyang He
Journal:  Oncogenesis       Date:  2021-07-22       Impact factor: 7.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.